arrow
A

Akihiro Ohba

Shizuoka Cancer Center
H指数:15
被引数:1,115

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancer

泛亚洲适应性ESMO临床实践指南:胰腺癌患者的诊断、治疗和随访

2025-10-090
OAAI
Electronic Patient-Reported Outcome Quality of Life Score in Japanese Patients With Pancreatic Cancer on Second-Line Chemotherapy: A Multicenter Observational Study

电子患者报告结局生活质量评分在日本胰腺癌二线化疗患者中的研究:一项多中心观察性研究

2025-08-260
OAAI
GnP vs mFOLFIRINOX or S-IROX in metastatic pancreatic cancer: 1-year follow-up updated data from the GENERATE (JCOG1611)

GnP与mFOLFIRINOX或S-IROX在转移性胰腺癌中的应用:GENERATE(JCOG1611)1年随访更新数据

2024-09-011
PRE
Efficacy of endoscopic ultrasound-guided gastroenterostomy using self-expandable metallic stent for afferent loop syndrome: A single-center retrospective study
2024-06-070
PRE
Diagnostic performance of EUS-guided tissue acquisition for solid pancreatic lesions ≤10 mm
2024-04-051
OAAI
Prospective clinical trial of EUS-guided choledochoduodenostomy without fistula dilation for malignant distal biliary obstruction

EUS引导下无瘘管扩张的胆总管十二指肠吻合术治疗恶性远端胆道梗阻的前瞻性临床试验

2023-09-283
OAAI
Standard versus delayed initiation of S-1 adjuvant chemotherapy after surgery for pancreatic cancer: a secondary analysis of a nationwide cohort by the Japan Pancreas Society
2023-06-174
OAAI
Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation
2023-05-085
PRE
A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407)

改良FOLFIRINOX与吉西他滨联合nab-紫杉醇治疗局部晚期胰腺癌的随机II期研究 (JCOG1407)

2023-03-0135
OAAI
Diagnostic Ability of Endoscopic Ultrasound-Guided Tissue Acquisition Using 19-Gauge Fine-Needle Biopsy Needle for Abdominal Lesions
2023-01-263
OAAI
Impact of S-1 adjuvant chemotherapy longer than 6 months on survival in patients with resected pancreatic cancer: a nationwide survey by the Japan Pancreas Society based on real-world data
CANCER
IF5.1
2022-12-123
PRE
Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meeting the OncoGuide™ NCC Oncopanel System analysis suitability criteria: a single-arm, phase II clinical trial
2022-10-0321
PRE
Safety and efficacy of S-IROX (S-1, irinotecan and oxaliplatin combination therapy) in patients with advanced pancreatic cancer: A multicenter phase 1b dose-escalation and dose-expansion clinical trial
2022-10-017
PRE